Journal Articles

Flivasorb® and the management of exudate

Share this article

Flivasorb® and the management of exudate

Clare Morris
31 May 2009

Wound care provides many challenges but none moreso than the management of high levels of exudate. The challenge is not only to be cost-effective and prevent maceration, but to improve the quality of life for the patient. Chronic wound fluid can be damaging to the wound healing process giving an added problem. This article examines the properties of Flivasorb® (Activa Healthcare), a wound dressing containing super absorbent polymer particles which not only absorbs high levels of exudate, but can retain the damaging particles in exudate, locking them inside the dressing.

Free for all healthcare professionals

Sign up to the Wounds Group journals





By clicking ‘Subscribe’, you are agreeing that the Wounds Group are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our privacy policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.

I am not a healthcare professional.